Healthcare Industry News: Jack Darby
News Release - March 3, 2010
AGA Medical Announces Promotion of Three Senior ExecutivesJack Darby Named Senior Vice President, Global Marketing and Distributor Sales;
Don O’Hearn Named Senior Vice President, Americas;
Gianluca Iasci Named Senior Vice President, Europe, Middle East and Africa
MINNEAPOLIS--(HSMN NewsFeed)--AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM ) today announced the promotion of three executives effective immediately. Jack Darby has been promoted to Senior Vice President, Global Marketing and Distributor Sales, Don O’Hearn has been promoted to Senior Vice President, Americas, and Gianluca Iasci has been promoted to Senior Vice President, EMEA (Europe, Middle East and Africa). The promotions reinforce AGA Medical’s commitment to global expansion and industry leadership.
President and Chief Executive Officer of AGA Medical John Barr commented, “I’m delighted to announce these important promotions. We have significantly strengthened our worldwide distribution channels over the last couple of years, which has included strategic additions to our senior management team. We believe we have built strong, scalable distribution organizations that are contributing to the growth of our business today and will be equally effective in launching our pipeline products upon completion of clinical trials and subsequent regulatory approvals.
“AGA Medical is committed to being geographically closer to the customer, and building lasting relationships that will enable us to accelerate growth in our structural heart and vascular franchises,” continued Barr. “Reinforcing our organization’s team will help us expand our leadership positions in all markets, including important emerging markets for AGA Medical, such as China, Brazil and India.”
As Senior Vice President, Global Marketing and Distributor Sales, Darby will continue to have responsibility for AGA Medical’s worldwide marketing effort, and manage Asia Pacific distributors with a particular focus on accelerating growth in key markets such as China, India and Japan. Darby joined AGA Medical in March 2007, most recently serving as Vice President, Worldwide Marketing and Distributor Sales. Prior to joining the company, he spent 14 years with CORDIS, a Johnson & Johnson company. Most recently, he served as its Vice President of Commercial Operations and Global Marketing.
As Senior Vice President, Americas, O’Hearn will continue to be responsible for AGA Medical’s direct sales in the United States and Canada, and will now also have responsibility for sales and distribution across Latin America. O’Hearn has served as Vice President, Sales North America for AGA Medical since March 2009. He previously held a number of positions during a 16-year tenure with Medtronic, Inc., most recently as its Vice President, U.S. Sales Operations and Field Education.
As Senior Vice President, EMEA, Iasci will continue to have responsibility for AGA Medical’s direct distribution in Europe, and will now also be responsible for managing its distributor relationships in Eastern Europe, the Middle East and Africa. Iasci joined AGA Medical as its Senior Vice President, Europe in September 2009. He has 20 years of experience in the medical device industry, working with Johnson & Johnson, Guidant (since acquired by Boston Scientific) and St. Jude Medical in a variety of senior sales and marketing roles throughout Europe and the Asia Pacific.
About AGA Medical
AGA Medical, based in Plymouth, Minnesota, is a leading innovator and manufacturer of medical devices for the treatment of structural heart defects and vascular abnormalities. AGA Medical’s AMPLATZER® occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be safe and highly effective in defect closure. AGA Medical is the only manufacturer with occlusion devices approved to close seven different structural heart defects, with leading market positions for each of its devices. More than 1,500 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets its AMPLATZER products in 112 countries worldwide to interventional cardiologists, electrophysiologists, interventional radiologists and vascular surgeons. More information about the company and its products can be found at http://www.amplatzer.com.
Source: AGA Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.